RIGL
Price
$28.03
Change
-$0.67 (-2.33%)
Updated
Sep 26, 01:25 PM (EDT)
Capitalization
514.8M
RNA
Price
$42.14
Change
+$1.30 (+3.18%)
Updated
Sep 26, 01:32 PM (EDT)
Capitalization
5.96B
46 days until earnings call
Interact to see
Advertisement

RIGL vs RNA

Header iconRIGL vs RNA Comparison
Open Charts RIGL vs RNABanner chart's image
Rigel Pharmaceuticals
Price$28.03
Change-$0.67 (-2.33%)
Volume$500
Capitalization514.8M
Avidity Biosciences
Price$42.14
Change+$1.30 (+3.18%)
Volume$400
Capitalization5.96B
RIGL vs RNA Comparison Chart in %
Loading...
RIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RIGL vs. RNA commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RIGL is a Buy and RNA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (RIGL: $28.70 vs. RNA: $40.84)
Brand notoriety: RIGL and RNA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RIGL: 101% vs. RNA: 43%
Market capitalization -- RIGL: $514.8M vs. RNA: $5.96B
RIGL [@Biotechnology] is valued at $514.8M. RNA’s [@Biotechnology] market capitalization is $5.96B. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RIGL’s FA Score shows that 1 FA rating(s) are green whileRNA’s FA Score has 0 green FA rating(s).

  • RIGL’s FA Score: 1 green, 4 red.
  • RNA’s FA Score: 0 green, 5 red.
According to our system of comparison, RIGL is a better buy in the long-term than RNA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RIGL’s TA Score shows that 4 TA indicator(s) are bullish while RNA’s TA Score has 4 bullish TA indicator(s).

  • RIGL’s TA Score: 4 bullish, 5 bearish.
  • RNA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, RIGL is a better buy in the short-term than RNA.

Price Growth

RIGL (@Biotechnology) experienced а -18.26% price change this week, while RNA (@Biotechnology) price change was -2.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.01%. For the same industry, the average monthly price growth was +9.06%, and the average quarterly price growth was +48.80%.

Reported Earning Dates

RNA is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RNA($5.96B) has a higher market cap than RIGL($515M). RIGL YTD gains are higher at: 70.630 vs. RNA (40.440). RIGL has higher annual earnings (EBITDA): 109M vs. RNA (-518.74M). RNA has more cash in the bank: 1.18B vs. RIGL (108M). RNA has less debt than RIGL: RNA (5.14M) vs RIGL (61M). RIGL has higher revenues than RNA: RIGL (268M) vs RNA (10.7M).
RIGLRNARIGL / RNA
Capitalization515M5.96B9%
EBITDA109M-518.74M-21%
Gain YTD70.63040.440175%
P/E Ratio5.29N/A-
Revenue268M10.7M2,505%
Total Cash108M1.18B9%
Total Debt61M5.14M1,188%
FUNDAMENTALS RATINGS
RIGL: Fundamental Ratings
RIGL
OUTLOOK RATING
1..100
53
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
PROFIT vs RISK RATING
1..100
90
SMR RATING
1..100
8
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RIGLRNA
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
75%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 5 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 15 days ago
84%
Bullish Trend 22 days ago
85%
Declines
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 16 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
RIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NEJYX22.15N/A
N/A
Natixis Vaughan Nelson Small Cap Y
FCDAX38.65N/A
N/A
Fidelity Advisor Stock Selector Sm Cp A
DGVRX94.60N/A
N/A
BNY Mellon Technology Growth I
NSMVX43.26N/A
N/A
North Star Micro Cap I
DFMLX38.51-0.37
-0.95%
DF Dent Midcap Growth Institutional Plus

RIGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, RIGL has been loosely correlated with MNMD. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if RIGL jumps, then MNMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RIGL
1D Price
Change %
RIGL100%
-5.22%
MNMD - RIGL
38%
Loosely correlated
-0.51%
RNA - RIGL
37%
Loosely correlated
-5.48%
AGIO - RIGL
37%
Loosely correlated
-1.90%
MIRM - RIGL
36%
Loosely correlated
-0.93%
FTRE - RIGL
36%
Loosely correlated
-5.81%
More